In Silico Drug Discovery for Treatment of Virus Diseases
- PMID: 35594021
- DOI: 10.1007/978-981-16-8969-7_4
In Silico Drug Discovery for Treatment of Virus Diseases
Abstract
Viral infections have remained a serious public health burden despite significant improvements in medical and pharmaceutical research in recent years. In silico approaches for drug discovery and design are fruitful for the management of a plethora of viral diseases. Virtual screening of libraries is performed using various computational tools to search for potential antiviral compounds. For this, a rational approach is used that comprises filtration of the screened compounds using docking, ligand- or pharmacophore-based similarity searches. The selected candidates are then tested in vitro to ascertain their biological activity. This minimizes the overall cost and time incurred in conventional drug designing methods. In this book chapter, we have discussed various methods of drug discovery and design, and their applications for the development of effective antiviral compounds. A descriptive methodology for the management of some common and notorious viral diseases is also outlined.
Keywords: Antiviral compounds; Docking; In silico drug discovery and design; Ligand; Pharmacophore; Viral diseases; Virtual screening.
© 2022. The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
Similar articles
-
In silico virtual screening approaches for anti-viral drug discovery.Drug Discov Today Technol. 2012 Autumn;9(3):e219-25. doi: 10.1016/j.ddtec.2012.07.009. Drug Discov Today Technol. 2012. PMID: 24990575 Free PMC article.
-
A Review of In Silico Approaches for Discovering Natural Viral Protein Inhibitors in Aquaculture Disease Control.J Fish Dis. 2025 Jul;48(7):e14120. doi: 10.1111/jfd.14120. Epub 2025 Mar 20. J Fish Dis. 2025. PMID: 40111154 Review.
-
Identification of novel VP35 inhibitors: Virtual screening driven new scaffolds.Biomed Pharmacother. 2016 Dec;84:199-207. doi: 10.1016/j.biopha.2016.09.034. Epub 2016 Sep 19. Biomed Pharmacother. 2016. PMID: 27657828
-
Discovery of selective dengue virus inhibitors using combination of molecular fingerprint-based virtual screening protocols, structure-based pharmacophore model development, molecular dynamics simulations and in vitro studies.J Mol Graph Model. 2018 Jan;79:88-102. doi: 10.1016/j.jmgm.2017.10.010. Epub 2017 Oct 24. J Mol Graph Model. 2018. PMID: 29156382
-
Structural biology in antiviral drug discovery.Curr Opin Pharmacol. 2016 Oct;30:116-130. doi: 10.1016/j.coph.2016.08.014. Epub 2016 Sep 6. Curr Opin Pharmacol. 2016. PMID: 27611878 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical